GO:0006520 | cellular amino acid metabolic process | 14.5% (19/131) | 4.86 | 0.0 | 0.0 |
GO:0043039 | tRNA aminoacylation | 10.69% (14/131) | 5.81 | 0.0 | 0.0 |
GO:0004812 | aminoacyl-tRNA ligase activity | 10.69% (14/131) | 5.81 | 0.0 | 0.0 |
GO:0043038 | amino acid activation | 10.69% (14/131) | 5.81 | 0.0 | 0.0 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 10.69% (14/131) | 5.81 | 0.0 | 0.0 |
GO:0016874 | ligase activity | 12.98% (17/131) | 4.92 | 0.0 | 0.0 |
GO:0006418 | tRNA aminoacylation for protein translation | 9.92% (13/131) | 5.82 | 0.0 | 0.0 |
GO:0140101 | catalytic activity, acting on a tRNA | 10.69% (14/131) | 5.16 | 0.0 | 0.0 |
GO:0019752 | carboxylic acid metabolic process | 14.5% (19/131) | 4.14 | 0.0 | 0.0 |
GO:0043436 | oxoacid metabolic process | 14.5% (19/131) | 4.14 | 0.0 | 0.0 |
GO:0006082 | organic acid metabolic process | 14.5% (19/131) | 4.13 | 0.0 | 0.0 |
GO:0044281 | small molecule metabolic process | 16.79% (22/131) | 3.63 | 0.0 | 0.0 |
GO:0006399 | tRNA metabolic process | 10.69% (14/131) | 4.95 | 0.0 | 0.0 |
GO:0034660 | ncRNA metabolic process | 11.45% (15/131) | 4.58 | 0.0 | 0.0 |
GO:0140098 | catalytic activity, acting on RNA | 12.21% (16/131) | 4.25 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 19.85% (26/131) | 2.88 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 19.85% (26/131) | 2.87 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 19.85% (26/131) | 2.83 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 18.32% (24/131) | 2.92 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 21.37% (28/131) | 2.58 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 16.03% (21/131) | 3.03 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 13.74% (18/131) | 3.28 | 0.0 | 0.0 |
GO:0035639 | purine ribonucleoside triphosphate binding | 21.37% (28/131) | 2.27 | 0.0 | 0.0 |
GO:0005524 | ATP binding | 19.85% (26/131) | 2.38 | 0.0 | 0.0 |
GO:0000166 | nucleotide binding | 22.9% (30/131) | 2.14 | 0.0 | 0.0 |
GO:1901265 | nucleoside phosphate binding | 22.9% (30/131) | 2.14 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 27.48% (36/131) | 1.87 | 0.0 | 0.0 |
GO:0032555 | purine ribonucleotide binding | 21.37% (28/131) | 2.2 | 0.0 | 0.0 |
GO:0017076 | purine nucleotide binding | 21.37% (28/131) | 2.19 | 0.0 | 0.0 |
GO:0032553 | ribonucleotide binding | 21.37% (28/131) | 2.19 | 0.0 | 0.0 |
GO:0032559 | adenyl ribonucleotide binding | 19.85% (26/131) | 2.3 | 0.0 | 0.0 |
GO:0030554 | adenyl nucleotide binding | 19.85% (26/131) | 2.3 | 0.0 | 0.0 |
GO:0036094 | small molecule binding | 22.9% (30/131) | 2.07 | 0.0 | 0.0 |
GO:0097367 | carbohydrate derivative binding | 21.37% (28/131) | 2.16 | 0.0 | 0.0 |
GO:0008144 | drug binding | 19.85% (26/131) | 2.27 | 0.0 | 0.0 |
GO:1901363 | heterocyclic compound binding | 31.3% (41/131) | 1.61 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 31.3% (41/131) | 1.61 | 0.0 | 0.0 |
GO:1901564 | organonitrogen compound metabolic process | 22.14% (29/131) | 1.98 | 0.0 | 0.0 |
GO:0043168 | anion binding | 21.37% (28/131) | 2.02 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 28.24% (37/131) | 1.61 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 28.24% (37/131) | 1.53 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 25.19% (33/131) | 1.63 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 55.73% (73/131) | 0.79 | 0.0 | 0.0 |
GO:0043167 | ion binding | 24.43% (32/131) | 1.55 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 21.37% (28/131) | 1.67 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 32.82% (43/131) | 1.18 | 0.0 | 1e-06 |
GO:0003676 | nucleic acid binding | 15.27% (20/131) | 2.02 | 0.0 | 1e-06 |
GO:0009987 | cellular process | 25.19% (33/131) | 1.39 | 0.0 | 2e-06 |
GO:0005488 | binding | 36.64% (48/131) | 0.99 | 1e-06 | 6e-06 |
GO:0003824 | catalytic activity | 35.11% (46/131) | 1.01 | 1e-06 | 7e-06 |
GO:0003723 | RNA binding | 6.87% (9/131) | 2.8 | 6e-06 | 4.7e-05 |
GO:0032040 | small-subunit processome | 2.29% (3/131) | 6.21 | 6e-06 | 4.8e-05 |
GO:0008150 | biological_process | 37.4% (49/131) | 0.87 | 6e-06 | 4.8e-05 |
GO:0009058 | biosynthetic process | 11.45% (15/131) | 1.98 | 6e-06 | 4.9e-05 |
GO:0030684 | preribosome | 2.29% (3/131) | 5.8 | 1.6e-05 | 0.000125 |
GO:0019238 | cyclohydrolase activity | 1.53% (2/131) | 7.21 | 4.5e-05 | 0.000338 |
GO:0044249 | cellular biosynthetic process | 9.16% (12/131) | 1.88 | 0.000107 | 0.000784 |
GO:0008652 | cellular amino acid biosynthetic process | 3.05% (4/131) | 3.93 | 0.000135 | 0.000978 |
GO:1901566 | organonitrogen compound biosynthetic process | 6.87% (9/131) | 2.19 | 0.000166 | 0.001176 |
GO:1901576 | organic substance biosynthetic process | 9.16% (12/131) | 1.8 | 0.000177 | 0.001235 |
GO:0000152 | nuclear ubiquitin ligase complex | 1.53% (2/131) | 6.21 | 0.000269 | 0.001815 |
GO:0005680 | anaphase-promoting complex | 1.53% (2/131) | 6.21 | 0.000269 | 0.001815 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 1.53% (2/131) | 5.89 | 0.000446 | 0.002917 |
GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 1.53% (2/131) | 5.89 | 0.000446 | 0.002917 |
GO:0044464 | cell part | 10.69% (14/131) | 1.47 | 0.000539 | 0.003477 |
GO:0044283 | small molecule biosynthetic process | 3.82% (5/131) | 2.86 | 0.000638 | 0.004053 |
GO:0000151 | ubiquitin ligase complex | 1.53% (2/131) | 5.63 | 0.000665 | 0.004161 |
GO:0044424 | intracellular part | 9.92% (13/131) | 1.49 | 0.000735 | 0.004528 |
GO:0000105 | histidine biosynthetic process | 1.53% (2/131) | 5.4 | 0.000927 | 0.005473 |
GO:0052803 | imidazole-containing compound metabolic process | 1.53% (2/131) | 5.4 | 0.000927 | 0.005473 |
GO:0006547 | histidine metabolic process | 1.53% (2/131) | 5.4 | 0.000927 | 0.005473 |
GO:0004252 | serine-type endopeptidase activity | 2.29% (3/131) | 3.94 | 0.000964 | 0.00561 |
GO:0016741 | transferase activity, transferring one-carbon groups | 4.58% (6/131) | 2.35 | 0.001177 | 0.006758 |
GO:0000049 | tRNA binding | 1.53% (2/131) | 5.21 | 0.001231 | 0.006971 |
GO:0005575 | cellular_component | 16.03% (21/131) | 1.02 | 0.001374 | 0.007674 |
GO:0019438 | aromatic compound biosynthetic process | 4.58% (6/131) | 2.3 | 0.001441 | 0.00774 |
GO:1990904 | ribonucleoprotein complex | 4.58% (6/131) | 2.3 | 0.001441 | 0.00774 |
GO:1901607 | alpha-amino acid biosynthetic process | 2.29% (3/131) | 3.75 | 0.001411 | 0.007781 |
GO:0003684 | damaged DNA binding | 1.53% (2/131) | 5.04 | 0.001576 | 0.008358 |
GO:0018130 | heterocycle biosynthetic process | 4.58% (6/131) | 2.26 | 0.001655 | 0.008667 |
GO:0046394 | carboxylic acid biosynthetic process | 3.05% (4/131) | 2.95 | 0.001829 | 0.009346 |
GO:0016053 | organic acid biosynthetic process | 3.05% (4/131) | 2.95 | 0.001829 | 0.009346 |
GO:0032991 | protein-containing complex | 7.63% (10/131) | 1.56 | 0.00216 | 0.010906 |
GO:1901362 | organic cyclic compound biosynthetic process | 4.58% (6/131) | 2.15 | 0.002384 | 0.01189 |
GO:1902494 | catalytic complex | 3.05% (4/131) | 2.77 | 0.002857 | 0.014083 |
GO:1901605 | alpha-amino acid metabolic process | 2.29% (3/131) | 3.34 | 0.003246 | 0.015815 |
GO:0004175 | endopeptidase activity | 3.05% (4/131) | 2.69 | 0.003495 | 0.01664 |
GO:0072522 | purine-containing compound biosynthetic process | 2.29% (3/131) | 3.31 | 0.003461 | 0.016668 |
GO:0005634 | nucleus | 3.05% (4/131) | 2.66 | 0.003775 | 0.017773 |
GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 1.53% (2/131) | 4.4 | 0.003896 | 0.01814 |
GO:0009073 | aromatic amino acid family biosynthetic process | 1.53% (2/131) | 4.31 | 0.004476 | 0.020386 |
GO:0008173 | RNA methyltransferase activity | 1.53% (2/131) | 4.31 | 0.004476 | 0.020386 |
GO:0005737 | cytoplasm | 2.29% (3/131) | 3.1 | 0.005209 | 0.023467 |
GO:0004643 | phosphoribosylaminoimidazolecarboxamide formyltransferase activity | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0006177 | GMP biosynthetic process | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0008297 | single-stranded DNA exodeoxyribonuclease activity | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0003937 | IMP cyclohydrolase activity | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0004536 | deoxyribonuclease activity | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0004529 | exodeoxyribonuclease activity | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0004826 | phenylalanine-tRNA ligase activity | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0004176 | ATP-dependent peptidase activity | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0003922 | GMP synthase (glutamine-hydrolyzing) activity | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0004358 | glutamate N-acetyltransferase activity | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0008409 | 5'-3' exonuclease activity | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0006144 | purine nucleobase metabolic process | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0046037 | GMP metabolic process | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0004635 | phosphoribosyl-AMP cyclohydrolase activity | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0004637 | phosphoribosylamine-glycine ligase activity | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0035312 | 5'-3' exodeoxyribonuclease activity | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0016895 | exodeoxyribonuclease activity, producing 5'-phosphomonoesters | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:1901070 | guanosine-containing compound biosynthetic process | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0009113 | purine nucleobase biosynthetic process | 0.76% (1/131) | 7.21 | 0.006745 | 0.02375 |
GO:0008168 | methyltransferase activity | 3.82% (5/131) | 2.16 | 0.005385 | 0.024005 |
GO:0016787 | hydrolase activity | 10.69% (14/131) | 1.07 | 0.006929 | 0.024194 |
GO:0017171 | serine hydrolase activity | 2.29% (3/131) | 3.04 | 0.005789 | 0.025268 |
GO:0008236 | serine-type peptidase activity | 2.29% (3/131) | 3.04 | 0.005789 | 0.025268 |
GO:0072521 | purine-containing compound metabolic process | 2.29% (3/131) | 2.96 | 0.00673 | 0.029071 |
GO:0009072 | aromatic amino acid family metabolic process | 1.53% (2/131) | 3.82 | 0.008719 | 0.030192 |
GO:0043227 | membrane-bounded organelle | 3.05% (4/131) | 2.29 | 0.009153 | 0.031181 |
GO:0043231 | intracellular membrane-bounded organelle | 3.05% (4/131) | 2.29 | 0.009153 | 0.031181 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 1.53% (2/131) | 3.69 | 0.010412 | 0.035183 |
GO:0098533 | ATPase dependent transmembrane transport complex | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0042455 | ribonucleoside biosynthetic process | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0003906 | DNA-(apurinic or apyrimidinic site) endonuclease activity | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0042451 | purine nucleoside biosynthetic process | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0046129 | purine ribonucleoside biosynthetic process | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0043190 | ATP-binding cassette (ABC) transporter complex | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0009163 | nucleoside biosynthetic process | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:1901659 | glycosyl compound biosynthetic process | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0006433 | prolyl-tRNA aminoacylation | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0004827 | proline-tRNA ligase activity | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0000178 | exosome (RNase complex) | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0030942 | endoplasmic reticulum signal peptide binding | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0009112 | nucleobase metabolic process | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0006526 | arginine biosynthetic process | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0005786 | signal recognition particle, endoplasmic reticulum targeting | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0005047 | signal recognition particle binding | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0046112 | nucleobase biosynthetic process | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0006420 | arginyl-tRNA aminoacylation | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:0004814 | arginine-tRNA ligase activity | 0.76% (1/131) | 6.21 | 0.013445 | 0.039396 |
GO:1990234 | transferase complex | 1.53% (2/131) | 3.35 | 0.016275 | 0.047357 |
GO:0043229 | intracellular organelle | 4.58% (6/131) | 1.55 | 0.016939 | 0.048949 |
GO:0043226 | organelle | 4.58% (6/131) | 1.55 | 0.017188 | 0.049327 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 2.29% (3/131) | 2.46 | 0.017465 | 0.049781 |